CDKN2A and melanoma: Of note, a significant increase in the number of p16Ink4a+/FSP‐1+ senescent fibroblasts (Strutz et al. 1995) was detected in close vicinity to malignant melanomas of old patients (> 60 years), but not of younger patients (< 45 years) (Figure 1D,E).